Live News EQUITY L impact Jul 10, 2026, 11:00 AM UTC

GSK: Artemis-8 Phase III Study Meets Primary Endpoint In Advanced Or Relapsed Small-Cell Lung Cancer

GSK: Artemis-8 Phase III Study Meets Primary Endpoint In Advanced Or Relapsed Small-Cell Lung Cancer

SQUAWKNEWS Updated Jul 10, 2026, 11:01 AM UTC

GSK: Artemis-8 Phase III Study Meets Primary Endpoint In Advanced Or Relapsed Small-Cell Lung Cancer